会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 91. 发明申请
    • CUSTOMER CONTROLLED VIDEO NETWORK
    • 客户控制的视频网络
    • US20140233585A1
    • 2014-08-21
    • US13773448
    • 2013-02-21
    • Scott BeersDavid AndersonBruce AndersonHoward Miller
    • Scott BeersDavid AndersonBruce AndersonHoward Miller
    • H04L12/937
    • H04L49/205H04L49/254H04L67/32H04N21/647H04N21/64707H04N21/64738
    • A technique for allowing customers to control a video network. A network controller receives a request from an end user for a video connection between a first port and a second port. The request may specify at least a start time, an end time, the first port and the second port. A plurality of available routes between the first port and the second port may be analyzed to determine at least one selected route that will be used to connect the first port and the second port. A first command may be sent to automatically connect the first port and the second port via the at least one selected route at the start time. While in progress, the video connection may be modified according to system availability. Customers may have a view of all requests that have been made, completed or reserved for in the future.
    • 一种允许客户控制视频网络的技术。 网络控制器从终端用户接收第一端口和第二端口之间的视频连接的请求。 该请求可以至少指定开始时间,结束时间,第一端口和第二端口。 可以分析第一端口和第二端口之间的多个可用路由,以确定将用于连接第一端口和第二端口的至少一个选择的路由。 可以发送第一命令以在开始时通过所述至少一个选择的路线自动地连接第一端口和第二端口。 在进行中,视频连接可能会根据系统的可用性进行修改。 客户可能会看到将来已经完成或预留的所有请求。
    • 92. 发明授权
    • Multi-functional tailgate for a vehicle
    • 用于车辆的多功能后挡板
    • US08740279B1
    • 2014-06-03
    • US13771610
    • 2013-02-20
    • Danja McGoffDavid AndersonGary BastianTrevor C. GarveyEugene Paik
    • Danja McGoffDavid AndersonGary BastianTrevor C. GarveyEugene Paik
    • B62D33/027B62D33/03B62D33/033
    • B62D33/0273E05B81/70E05B81/76E05B83/12E05B83/20
    • A tailgate can include first and second frames, doors and sets of touchpads. The frames can be coupled to the vehicle to selectively pivot about a first axis, and can be selectively coupled to the vehicle via respective frame latches. The doors can be coupled to the respective frames to selectively pivot about a second axis perpendicular to the first axis and relative to the frames, and can be selectively coupled to the frames via respective door latches. The sets of touchpads can be operably connected with the respective doors and frame and door latches. Actuation of one or both sets of touchpads in different configurations can facilitate opening one or both of the doors independent of or with each other in a first configuration pivoting about the first axis with the respective frames, or in a second configuration pivoting about the second axis relative to the respective frames.
    • 后挡板可以包括第一和第二框架,门和一组触摸板。 框架可以联接到车辆以选择性地围绕第一轴线枢转,并且可以经由相应的框架闩锁选择性地联接到车辆。 门可以联接到相应的框架以选择性地围绕垂直于第一轴线和相对于框架的第二轴线枢转,并且可以经由相应的门闩锁选择性地联接到框架。 触摸板组可以与相应的门和框架和门闩锁可操作地连接。 一组或两组不同结构的触摸板的致动可以有助于在第一构型中独立于彼此或彼此相互打开一个或两个门,该第一构型围绕第一轴线与相应的框架一起旋转,或者以围绕第二轴线枢转的第二构造 相对于各个框架。
    • 97. 发明授权
    • Treatment using dantrolene
    • 使用丹曲林治疗
    • US08110225B2
    • 2012-02-07
    • US12717588
    • 2010-03-04
    • David AndersonBenjamin G. Cameransi, Jr.Vincent M. Conklin
    • David AndersonBenjamin G. Cameransi, Jr.Vincent M. Conklin
    • A61K9/14A61K9/00A61K31/415
    • A61K31/4178A61K9/0019A61K9/10A61K9/1274A61K9/1623A61K9/1635A61K9/1652A61K9/19A61K31/4166A61K47/10A61K47/18C07D233/80
    • Provided are low-volume, safe for injection formulations of dantrolene yielding significant advantages over the currently approved and marketed dantrolene for malignant hyperthermia (MH) threatening anesthetic crisis. Once dantrolene can be made immediately available to patients triggered of MH, the anesthesiologist will be able to focus exclusively on the management of the patient's physiologic status in this complex and evolving crisis, not on the laborious and time consuming reconstitution process of the rescue agent. The low volume, safe for injection formulations of dantrolene have significant advantages over currently used approaches to the prevention and treatment of pumphead, and other neurological, cognitive and motor dysfunction incident to iatrogenically or trauma induced situations of altered blood flow, including those incurred during surgical procedures involving CPB or related procedures, as well as those incurred during non-normothermic episodes caused iatrogenically or by disease.
    • 提供的低容量,安非他酮注射剂配方,与目前批准和销售的用于恶性高热(MH)威胁性麻醉危机的丹曲林相比,具有显着的优势。 一旦丹培罗林可以立即提供给触发MH的患者立即使用,麻醉师将能够专注于在这个复杂而不断演变的危机中对患者生理状况的管理,而不是在救援人员的费力和耗时的重组过程中。 丹那罗林注射剂配方的体积小,安全性高于目前使用的泵头预防和治疗方法,以及其他神经系统,认知功能障碍和运动功能障碍对医源性或创伤引起的血流变化情况的影响,包括外科手术 涉及CPB或相关程序的程序,以及在非正常体温发作期间由医源性或疾病引起的程序。
    • 100. 发明授权
    • Treatment using dantrolene
    • 使用丹曲林治疗
    • US07758890B2
    • 2010-07-20
    • US10788413
    • 2004-03-01
    • David AndersonBenjamin G. Cameransi, Jr.Vincent M. Conklin
    • David AndersonBenjamin G. Cameransi, Jr.Vincent M. Conklin
    • A61K9/14A61K9/00A61K31/415
    • A61K31/4178A61K9/0019A61K9/10A61K9/1274A61K9/1623A61K9/1635A61K9/1652A61K9/19A61K31/4166A61K47/10A61K47/18C07D233/80
    • Low volume safe for injection formulations of dantrolene yield significant advantages over the currently approved and marketed dantrolene for MH threatening anesthetic crisis. Once dantrolene can be made immediately available to patients triggered of MH, the anesthesiologist will be able to focus exclusively on the management of the patient's physiologic status in this complex and evolving crisis, not on the laborious and time consuming reconstitution process of the rescue agent. Additionally, a safe for injection low volume formulation of dantrolene can be made widely available to non-anesthesiologist practitioners who have occasion to use dantrolene intravenously in the treatment of other potentially life threatening conditions, including in the field. The low volume, safe for injection formulations of dantrolene, as well as other formulations of dantrolene, have significant advantages over currently used approaches to the prevention and treatment of pumphead, and other neurological, cognitive and motor dysfunction incident to iatrogenically or trauma induced situations of altered blood flow, including those incurred during surgical procedures involving CPB or related procedures, as well as those incurred during non-normothermic episodes caused iatrogenically or by disease.
    • 低剂量安非他酮注射剂配方,与目前批准和上市的丹曲林相比,具有威胁麻醉危险的MH。 一旦丹培罗林可以立即提供给触发MH的患者立即使用,麻醉师将能够专注于在这个复杂而不断演变的危机中对患者生理状况的管理,而不是在救援人员的费力和耗时的重组过程中。 另外,可以广泛使用非麻醉医师从事静脉内使用丹曲罗治疗其他潜在危及生命的疾病,包括在现场的非麻醉医师。 对于预防和治疗泵头以及其他神经系统,认知和运动功能障碍,医源性或创伤性诱发的情况,丹那罗林的低体积,安全注射剂型以及其他丹曲林制剂具有显着优点。 改变的血液流量,包括涉及CPB或相关手术的手术过程中发生的血流量以及在医源性或疾病引起的非正常体温发作期间发生的血流量。